glp 1 drugs for weight loss price The Rising Tide of GLP-1 Costs: Can Your Health Plan Stay Afloat? Cost Savings From GLP-1 Weight

World Obesity Federation, 2022)

In addition, the SUMMIT trial evaluates the effect of tirzepatide (the GLP-1/GIP dual receptor agonist) in people with obesity-related HFpEF (Clinicaltrials.gov ID NCT04847557)

Song X, Jia H, Jiang Y, Wang L, Zhang Y, Mu Y, et al

This allows for the evaluation of the overall competition within the market

NIDDK notes that these medications act on receptors in the brain in ways that help decrease appetite, reduce cravings, and signal fullness

Predictive biomarkers: Further evidence should emerge in identifying predictive biomarkers that could help identify which patients are most likely to benefit from GLP-1 RAs and SGLT2is, and their combination, in the management of PCOS